Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

European approval for 3-in-1 version of Exforge

October 23, 2009 Sales and Marketing Diovan, Exforge, Novartis, cv, hypertension

European regulators have approved an expanded version of Novartis’ high blood pressure treatment Exforge.Exforge was first approved in Europe in …
News

Januvia helps stabilise Merck sales

October 23, 2009 Sales and Marketing Januvia, Merck

 Merck has turned in stable figures for the third quarter of the year, with global sales up 2% on the …
News

Cost-cutting helps Pfizer’s bottom line

October 22, 2009 Sales and Marketing Pfizer

Pfizer's third-quarter results have seen it reap the benefit of its cost-cutting measures, including a reduction in headcount of around …
News

EFPIA starts anti-counterfeiting pilots in Sweden

October 21, 2009 Manufacturing and Production, Sales and Marketing EU, counterfeits, supply chain

More than 100,000 products and 25 retail pharmacies in Stockholm will take part in a two-month anti-counterfeiting project run by …
News

Barbara Britten, business developement director, Pharmexx UK

October 21, 2009 Sales and Marketing appointment, pharmexx, sales and marketing

Barbara Britten has joined Pharmexx UK as a business developement director.She most recently worked at Actelion, where she held the …
Appointment

UK begins swine flu vaccinations with GSK jab

October 21, 2009 Sales and Marketing h1n1, hc

The UK's swine flu vaccination programme began today with NHS hospitals offering the jabs to frontline healthcare workers and patients …
News

GSK kidney cancer drug approved in US

October 20, 2009 Research and Development, Sales and Marketing Cancer, GSK, rcc

 GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …
News

First details emerge of Pfizer site closures

October 20, 2009 Research and Development, Sales and Marketing MA, Pfizer, restructure

 The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …
News

GSK’s Cervarix finally wins US approval

October 19, 2009 Sales and Marketing Cervarix, GSK, US

US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …
News

AZ-BMS launch Onglyza in Europe

October 19, 2009 Sales and Marketing AZ, BMS, DPP-4, Onglyza, diabetes

 Bristol-Myers Squibb and AstraZeneca’s long-awaited type II diabetes drug Onglyza has been launched in the UK, its first European market.Designed …
News

Quality regulator slams NHS trusts

October 16, 2009 Sales and Marketing NHS, hc

The Care Quality Commission has slammed nearly 50 NHS trusts in its latest annual report on the care which patients …
News

Johnson & Johnson rides out patent attack

October 16, 2009 Sales and Marketing JJ, generics

 Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …
News

Tamiflu windfall helps Roche to bumper sales growth

October 15, 2009 Sales and Marketing Roche, Tamiflu

 Roche has raised its sales growth prediction for 2009 on the back of a strong third quarter and record sales …
News

Pfizer completes Wyeth merger

October 15, 2009 Sales and Marketing MA, Pfizer, restructure

Pfizer expects to complete its $68 billion acquisition of Wyeth today after receiving sign-off on the deal from regulators in …
News

US health reform clears first hurdle

October 14, 2009 Sales and Marketing Obama, Senate, US, US healthcare, hc, reform

The US Senate has approved the bill to reform America’s health care system, raising hopes that it can become law …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026